Showing results (171-180 of 521) with videos related to
Sort By:
Pageof 53
Journal of Environmental Monitoring : JEM|June 14, 2011
Monitoring of pharmaceutically active compounds on the Guadalquivir River basin (Spain): occurrence and risk assessmentJ Martín, D Camacho-Muñoz, J L Santos, et al.Archives of Medical Research|January 1, 1997
Attitudes regarding molecular diagnosis in Mexican families at risk of inheriting Huntington's diseaseC Garcia de la Cadena, M E Alonso, A Ochoa, et al.Journal of Hazardous Materials|May 22, 2012
Occurrence of pharmaceutical compounds in wastewater and sludge from wastewater treatment plants: removal and ecotoxicological impact of wastewater discharges and sludge disposalJ Martín, D Camacho-Muñoz, J L Santos, et al.Archivos De Bronconeumologia|February 15, 2003
[Non-small cell lung cancer. Survival after radiotherapy and prognostic factors]J Jaén Olasolo, E Alonso Redondo, A León Jiménez, et al.Molecular and Cellular Biochemistry|February 1, 1988
Effects of inhibition of ornithine aminotransferase or of general aminotransferases on urea and citrulline synthesis and on the levels of acetylglutamate in isolated rat hepatocytesF Aniento, A Garcia-España, M Portolés, et al.Neurologia (Barcelona, Spain)|November 30, 2004
[Influence of levodopa on cognition of idiopathic Parkinson's disease]E Alonso-Prieto, E Michel-Esteban, C Trujillo-Matienzo, et al.Neuropediatrics|November 9, 2000
Huntington disease in children: genotype-phenotype correlationA Rasmussen, R Macias, P Yescas, et al.Journal of Psychiatry & Neuroscience : JPN|July 1, 1995
Clinico-pathological correlation in dementiasF Teixeira, E Alonso, V Romero, et al.The Science of the Total Environment|November 10, 2009
Occurrence and risk assessment of nonylphenol and nonylphenol ethoxylates in sewage sludge from different conventional treatment processesM M González, J Martín, J L Santos, et al.Revista Espanola De Anestesiologia Y Reanimacion|January 21, 2015
Comparison of the hemodynamic response to induction and intubation during a target-controlled infusion of propofol with 2 different pharmacokinetic models. A prospective ramdomized trialA Ramos Luengo, F Asensio Merino, M S Castilla, et al.Pageof 53